Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging studyMark C. Genovese, Jeffrey Kaine, Mitchell B. Lowenstein et al.|Arthritis & Rheumatism|2008Cited by 206
Abatacept for Crohn's Disease and Ulcerative ColitisWilliam J. Sandborn, Stephen B. Hanauer, Paul Rutgeerts et al.|Gastroenterology|2012Cited by 142